Hong Kong IPO: WuXi Biologics unit eyes up to US$520 million in biotech push WuXi XDC, a 60 per cent-owned unit of WuXi Biologics, could raise as much as US$520 million, including excess share ...
who served on the staff of the House of Representatives' Select Committee on China, for a key post in the U.S.-China tech battle. January 6, 2025 China's WuXi Biologics to sell Irish vaccine ...